ungdomar i park2.png

Swipp

Projects

 

SWIPP selects projects
characterized by:

• Safe and well-established drug substances
• Limited clinical programs
• Hybrid / 505(b)(2) regulatory routes
• Niche patient groups
• Less than 5 years from conception to EU market authorization